Top of the morning to you. A spot of snow is falling on the Pharmalot corporate campus this morning, which dampens our hopes that spring is near. To keep warm, yes, we are brewing a cup of stimulation. How else to cope with gray skies and dank temperatures? Nonetheless, we will persevere and we are sure that you will, as well. So time to get on with it. Here are some items of interest from around that big old pharmaceutical world. Take a look, and keep us in mind if your hear something interesting yourself...
Pharmaceutical Traces Found In Long Island Drinking Water (LongIsland.com)
UK's NICE Backs Novartis Xolair Asthma Drug After All (Reuters)
Teva Faces Israeli Backlash Over Job Cuts (Bloomberg News)
US Court Rejects Class-Action Suit Against Ranbaxy Over Lipitor (CNBC)
Glaxo CEO Peformance Pay Cut In Half (Pharma Times)
Merck Cuts 280 Jobs In Ireland (Newstalk)
Merck KGgA Not Planning Big Acquistions This Year (Reuters)
Roche's Rituxan Cures Rare Skin Disease In Study (Bloomberg News)
Novartis Says Rituxan Biosimilar Is On Track (Bloomberg News)
Drugmaker Flees Venezuela For Florida (Sun-Sentinel)
EMA May Hike Drug Review Fees By 2.6 Percent (InPharma Technologist)
Thailand Expects Free Trade Deal With EU In Two Years (The Nation)
Jubilant Life Sciences Gets FDA Warning Letter (Outsourcing Pharma)
EDITOR'S NOTE: Please check this post for additional items during the day
morning coffee pic thx to chichacha on flickr